Highlights Relay Therapeutics, Inc.

Equities

RLAY

US75943R1023

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
8.24 ^USD	+6.19%		+29.56%	-25.16%

Jun. 12	Transcript : Relay Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM
Jun. 06	Transcript : Relay Therapeutics, Inc. - Special Call

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment	Jun. 05	DJ
Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment	Jun. 05	MT
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with Rly-2608	Jun. 05	CI
Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q1 Revenue $10M	May. 02	MT
Relay Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Relay Therapeutics Q4 Loss Widens, Reports No Revenue	Feb. 23	MT
Relay Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Relay Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q3 Revenue $25.2M	Nov. 02	MT
Relay Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Relay Therapeutics, Inc. Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors	23-10-12	CI
Relay Therapeutics' Q2 Loss Widens	23-08-09	MT
Relay Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q2 Revenue $119,000	23-08-08	MT
Relay Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
Relay Therapeutics, Inc. Announces Initial Clinical Data Demonstrating That Rly-2608 Selectively Targets Multiple PI3KaMutations	23-04-18	CI
Relay Therapeutics' Q4 Loss Narrows, Revenue Falls	23-02-24	MT
Earnings Flash (RLAY) RELAY THERAPEUTICS Posts Q4 Revenue $253M	23-02-23	MT
Relay Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23	CI
Relay Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Relay Therapeutics, Inc.

Equities

RLAY

US75943R1023

Highlights

Filters